Combating COVID-19 with mesenchymal stem cell therapy

The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The virus mainly targets the pulmonary epithelial cells as it’s initial site of infection by letting its surface spike protein interact and bind to the host ACE2 receptor. The internalization and gradual replication o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajarshi, Keshav, Chatterjee, Aroni, Ray, Shashikant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224671/
https://www.ncbi.nlm.nih.gov/pubmed/32420049
http://dx.doi.org/10.1016/j.btre.2020.e00467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224671/
https://www.ncbi.nlm.nih.gov/pubmed/32420049
http://dx.doi.org/10.1016/j.btre.2020.e00467

Ejemplares similares